Literature DB >> 4851019

Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma).

S F Tolchin, A Winkelstein, G P Rodnan, S F Pan, H R Nankin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4851019     DOI: 10.1002/art.1780170406

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  9 in total

Review 1.  Systemic sclerosis: is there a treatment yet?

Authors:  C M Black
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

Review 2.  Effects of immunomodulating therapy in systemic sclerosis.

Authors:  F H van den Hoogen; A M Boerbooms; L B van de Putte
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

3.  Sarcoma complicating therapy with cyclophosphamide.

Authors:  J S Marks; C L Scholtz
Journal:  Postgrad Med J       Date:  1977-01       Impact factor: 2.401

4.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

5.  Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs.

Authors:  A Winkelstein
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

Review 6.  Combination therapy: the risks of infection and tumor induction.

Authors:  D E Yocum
Journal:  Springer Semin Immunopathol       Date:  2001

7.  Chromosomal changes in rheumatoid arthritis patients treated with CPH82.

Authors:  S Rantapää Dahlqvist; I Nordenson
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

8.  Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.

Authors:  P Lewis; B L Hazleman; R Hanka; S Roberts
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

Review 9.  Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.

Authors:  R Luqmani; C Gordon; P Bacon
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.